Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
2d
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback